文献速递头颈神经MR

T1、T2 mapping技术定量评估早期2型糖尿病性白内障

Quantitative assessment of early Type 2 diabetic cataracts using T1,T2-mapping techniques.
PubMed 文献 · Br J Radiol · 2019-08-09

前瞻性纳入28例2型糖尿病患者与28例非糖尿病对照,行3.0T眼眶MRI T1、T2 mapping,测量晶状体核弛豫时间。糖尿病组晶状体T1、T2值均高于对照组(P<0.01),且与糖化血红蛋白相关;作者认为该技术可较裂隙灯更早发现晶状体异常。

要点

  • 糖尿病组晶状体核T1值626.7±56.8、T2值29.4±5.6,均高于非糖尿病组的581.6±64.7与24.8±8.6(P<0.01)。
  • 晶状体T1、T2值与糖化血红蛋白(HbA1c)相关,相关系数分别为0.502和0.396。
  • 作者认为T1、T2 mapping可较裂隙灯更早发现晶状体异常改变,可能成为早期晶状体病变的有效诊断方法。

核心结论

  • T1、T2 mapping技术能敏感反映糖尿病患者晶状体弛豫时间的改变,可较裂隙灯更早发现异常变化,可能成为早期晶状体病变的有效诊断方法。

研究设计与样本

  • 前瞻性研究,纳入28例2型糖尿病患者,另收集28例非糖尿病患者作为对照组。
  • 所有纳入者均行眼科检查,并在Siemens-Skyra 3.0T扫描仪上行眼眶MRI T1、T2 mapping检查。
  • 基于Siemens-Syngo工作站以感兴趣区(ROI)法测量晶状体核的T1、T2值,采用两样本t检验分析组间差异,并以Pearson相关分析弛豫时间与空腹血糖、糖化血红蛋白等临床变量的相关性。

关键影像表现/征象

  • 糖尿病组晶状体核T1值为626.7±56.8,非糖尿病组为581.6±64.7,糖尿病组高于对照组(P<0.01)。
  • 糖尿病组晶状体核T2值为29.4±5.6,非糖尿病组为24.8±8.6,糖尿病组高于对照组(P<0.01)。

诊断标准与关键数值

  • 以P<0.01作为判断统计学显著性的标准。
  • 糖尿病组晶状体T1、T2值与糖化血红蛋白(HbA1c)显著相关,相关系数分别为0.502和0.396。

临床应用与阅片要点

  • 作者认为T1、T2 mapping技术可较裂隙灯检查更早发现晶状体异常改变,可能成为早期晶状体病变的有效诊断方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to explore the feasibility of T1 and T2-mapping techniques in evaluating early Type 2 diabetic cataracts.

METHODS: Totally, 28 patients with Type 2 diabetes was prospectively collected, and 28 non-diabetic patients were collected as control group. All patients included had ophthalmological exploration and all patients underwent orbital MRI examination with T1 and T2-mapping on a Siemens-Skyra 3.0T scanner. T1 and T2 values of the lens nucleus were measured by region of interest (ROI) method based on Siemens-Syngo workstation. Two sample t-test was used to analyze the differences between groups. Pearson correlations were calculated between relaxation time (T1, T2) and clinical variables, such as fasting glucose, glycosylated hemoglobin etc. p < 0.01 was used to determine statistical significance.

RESULTS: In Type 2 diabetes group, the T1 value was 626.7 ± 56.8, T2 value was 29.4 ± 5.6. In non-diabetic group, the T1 value was 581.6 ± 64.7, T2 value was 24.8 ± 8.6. The T1 and T2 values of the lens in diabetic group were significantly higher than those in control group (p < 0.01, T1 value: 626.7 ± 56.8 vs 581.6 ± 64.7; T2 value: 29.4 ± 5.6 vs 24.8 ± 8.6). The T1 and T2 values of lens in diabetic patients were significantly correlated with glycosylated hemoglobin (HbA1c), and the correlation coefficients were 0.502 and 0.396, respectively.

CONCLUSION: T1 and T2-mapping technique can sensitively reflect the alterative relaxation time of lens in diabetic patients. This technique can find abnormal changes earlier than slit lamp, and may be effective diagnostic methods for early lens disease.

ADVANCES IN KNOWLEDGE: T1 and T2-mapping techniques may be effective diagnostic methods for early lens disease, which can detect abnormal changes earlier than slit lamp examination.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Ma J, Xu X, Wang S, et al. Quantitative assessment of early Type 2 diabetic cataracts using T1,T2-mapping techniques. Br J Radiol. 2019. PMID: 31398062. doi:10.1259/bjr.20181030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。